These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7308291)

  • 21. Nigroamygdaloid dopamine neurons: nigral modulation of their activity.
    Leviel V; Charriere B; Fayada C; Guibert B
    Brain Res; 1986 Sep; 381(2):205-14. PubMed ID: 3019477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of histamine H2 receptor in rat hypothalamus releases endogenous norepinephrine.
    Blandina P; Knott PJ; Leung LK; Green JP
    J Pharmacol Exp Ther; 1989 Apr; 249(1):44-51. PubMed ID: 2709335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo release of newly synthesized catecholamines from the hypothalamus by amphetamine.
    Philippu A; Glowinski J; Besson MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(1):1-8. PubMed ID: 4275627
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study.
    Seyfried CA
    Biochem Pharmacol; 1983 Aug; 32(15):2329-31. PubMed ID: 6136281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Deoxy-D-glucose and insulin modify release of norepinephrine from rat hypothalamus.
    McCaleb ML; Myers RD
    Am J Physiol; 1982 May; 242(5):R596-603. PubMed ID: 7044152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
    Taylor KM; Snyder SH
    Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo release of angiotensin II from the rat hypothalamus.
    Brosnihan KB; Schiavone MT; Sprunger AE; Chappell MC; Rizzo M; Ferrario CM
    Hypertension; 1988 Feb; 11(2 Pt 2):I158-62. PubMed ID: 3346050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effect of prolactin on dopamine release from the rat dorsal and ventral striatum and from the mediobasal hypothalamus superfused in vitro.
    Chen JC; Ramirez VD
    Eur J Pharmacol; 1988 Apr; 149(1-2):1-8. PubMed ID: 2456219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesicular accumulation of dopamine following L-DOPA administration.
    Buu NT
    Biochem Pharmacol; 1989 Jun; 38(11):1787-92. PubMed ID: 2735936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid binding in the rostral hypothalamus is reduced following lesion of the ventral noradrenergic tract in female rats.
    Dyer RG; Parvizi N; Hollingsworth S; Mansfield S; Heavens RP; Bicknell RJ; Sirinathsinghji DJ
    Exp Brain Res; 1991; 85(1):230-4. PubMed ID: 1653147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interactions of dopamine receptor agonists and antagonists with regard to dopamine synthesis and metabolism].
    Kehr W
    Arzneimittelforschung; 1976; 26(6):1086-8. PubMed ID: 9107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometric measurement of catecholamine turnover in rat hypothalamus after long-term L-dopa infusion.
    Freed CR; Murphy RC
    J Pharmacol Exp Ther; 1978 Jun; 205(3):702-9. PubMed ID: 660538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hyperprolactinemia causes progressive changes in hypothalamic dopaminergic and noradrenergic neurons.
    Simpkins JW; Gabriel SM
    Brain Res; 1984 Sep; 309(2):277-82. PubMed ID: 6478222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications.
    Hoebel BG; Hernandez L; Schwartz DH; Mark GP; Hunter GA
    Ann N Y Acad Sci; 1989; 575():171-91; discussion 192-3. PubMed ID: 2699187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine.
    Borsini F; Bendotti C; Carli M; Poggesi E; Samanin R
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):3-11. PubMed ID: 515507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry.
    Kitahama K; Geffard M; Araneda S; Arai R; Ogawa K; Nagatsu I; Pequignot JM
    Brain Res; 2007 Sep; 1167():56-70. PubMed ID: 17692830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines.
    Guillaume V; Conte-Devolx B; Szafarczyk A; Malaval F; Pares-Herbute N; Grino M; Alonso G; Assenmacher I; Oliver C
    Neuroendocrinology; 1987 Aug; 46(2):143-6. PubMed ID: 2819759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis.
    Zetterström T; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1986 Jun; 376(1):1-7. PubMed ID: 3087581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.